Sort
130,381 grants matching “hiv”
Structure-Based CD-4-gp120 Antagonism
$1,345,280Drexel University · P01 · FY2002 · GM
Enhancing Independence in Elders with Serious Illness
$1,345,224R. Sean Morrison · Icahn School Of Medicine At Mount Sinai · P30 · FY2025 · AG
Structural studies of native-like SOSIP trimers
$1,345,161Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2016 · AI
Cornell Clinical Trials Unit
$1,345,095Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2009 · AI
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$1,345,060John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Clinical Research Correlatives Core
$1,345,055Kaska Wloka · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Administrative Core
$1,345,022Alice Telesnitsky · University Of Michigan At Ann Arbor · U54 · FY2019 · AI
Health Promotion and Disease Prevention Research Centers
$1,345,000Gregory Michael Rebchook · University Of California, San Francisco · U48 · FY2023 · DP
Novel Adjunctive Therapies for NeuroAIDS
$1,344,864Harris A Gelbard · University Of Rochester · P01 · FY2014 · MH
Novel Adjunctive Therapies for NeuroAIDS
$1,344,864Harris A Gelbard · University Of Rochester · P01 · FY2012 · MH
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,344,787University Of Hawaii At Manoa · U01 · FY2001 · AI
Computation & Chemistry Core
$1,344,651Gregory A. Voth · Seattle Children'S Hospital · U54 · FY2024 · AI
New York University HIV/AIDS Clinical Trial Unit
$1,344,582Judith Ann Aberg · New York University School Of Medicine · UM1 · FY2013 · AI
Alphavirus Replicon Vaccines against Botulinum Neurotox*
$1,344,570Alphavax Human Vaccines, Inc. · U01 · FY2003 · AI
Preclinical Development of HIV-1 Vif Antagonists
$1,344,436Mario Stevenson · Univ Of Massachusetts Med Sch Worcester · U19 · FY2007 · MH
MPOPHC: Integrating human risk perception and social processes into policy responses in an epidemiological model
$1,344,200Brian Beckage · University Of Vermont & State Agricultural College · · FY2024 · MPS
HIV-1 Reverse Transcriptase
$1,344,189Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
HIV-1 Integrase
$1,344,189Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Basic and Clinical Studies of CpG ODN in HIV Disease
$1,344,163Alan L Landay · Rush University Medical Center · U19 · FY2006 · AI
PS04-012, HIV PREVENTION PROJECTS
$1,344,149Mary Ann Ann Cooney · Nh State Dept/Hlth Statistics/Data Mgmt · U62 · FY2009 · PS
Preclinical and Clinical Studies in Gene Therapy for Sickle Cell Disease
$1,344,142John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Mechanisms of Immune Activation and Disease Progression in Animal Models
$1,343,988Jason Brenchley · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Natl Resource for Mass Spectrom of Biolog Macromolecules
$1,343,896Brian T Chait · Rockefeller University · P41 · FY2011 · RR
PROTEASE INHIBITORS IN THE HOMELESS--A COHORT STUDY
$1,343,847University Of California San Francisco · R01 · FY2000 · MH
Structural basis for activity of and resistance to HIV integrase inhibitors
$1,343,802Dmitry Lyumkis · Salk Institute For Biological Studies · U01 · FY2025 · AI